GDNF gene therapy - Genetic Therapy
Alternative Names: Glial cell line-derived neurotrophic factor gene therapy - Genetic Therapy; Parkinson's disease gene therapy - Genetic TherapyLatest Information Update: 25 Sep 2021
At a glance
- Originator Genetic Therapy; University of Rochester
- Class Antiparkinsonians; Gene therapies; Neuroprotectants
- Mechanism of Action Glial cell line-derived neurotrophic factor expression stimulants; Neuron stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Parkinson's disease
Most Recent Events
- 20 Jun 2001 No-Development-Reported for Parkinson's disease in USA (Unknown route)
- 01 May 1997 Preclinical development for Parkinson's disease in USA (Unknown route)